We assessed differences in survival between non-Hispanic black (NHB) and non-Hispanic
white (NHW) patients with multiple myeloma (MM), and the sequential effects of patient …

The prevalence of multiple myeloma (MM) is increasing in Nordic countries and the rest of
the western world. Patients aged≥ 75 years at diagnosis constitute an increasing proportion …

Survival in multiple myeloma (MM) has developed favorably over the past decades for
reasons that have been ascribed to new medications and treatment. However, development …

Lipid metabolism is intrinsically linked to tumorigenesis. And one of the most important
characteristics of cancer is the modification of lipid metabolism and its correlation with …

Plasma cell leukemia (PCL) is an aggressive form of multiple myeloma (MM), characterized
by circulating malignant plasma cells in the blood. ItLs either primary or evolves from MM. In …

Background and aims To systematically investigate all relevant evidence on the association
between high-density lipoprotein cholesterol (HDL-C) and multiple myeloma (MM). Methods …

This study aimed to determine the incidence and prevalence of multiple myeloma (MM) in
Finland in 2015–2019, to characterize adult patients newly diagnosed with MM, and to …

Aims: To evaluate the validity of recorded chronic disease diagnoses in Icelandic healthcare
registries. Methods: Eight different chronic diseases from multiple sub-specialties of …

Background Monoclonal gammopathies are a group of disorders associated with clonal
proliferation of plasma cells that produces a monoclonal protein. Aims The main objective of …

Background Muscle mass and strength are severely compromised in patients diagnosed
with multiple myeloma, such that the risk of poor overall survival increases as the prevalence …